Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 4/6 |
Past Performance | 1/6 |
Financial Health | 4/6 |
Dividends | 4/6 |
SN. Stock Overview
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide.
Smith & Nephew plc Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | UK£10.54 |
52 Week High | UK£14.41 |
52 Week Low | UK£10.02 |
Beta | 0.40 |
1 Month Change | -6.48% |
3 Month Change | -17.40% |
1 Year Change | -23.87% |
3 Year Change | -44.45% |
5 Year Change | -22.95% |
Change since IPO | 553.31% |
Recent News & Updates
These 4 Measures Indicate That Smith & Nephew (LON:SN.) Is Using Debt Reasonably Well
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
There Are Reasons To Feel Uneasy About Smith & Nephew's (LON:SN.) Returns On Capital
If you're looking for a multi-bagger, there's a few things to keep an eye out for. Amongst other things, we'll want to...
Shareholder Returns
SN. | GB Medical Equipment | GB Market | |
---|---|---|---|
7D | -1.5% | -1.6% | 0.4% |
1Y | -23.9% | -19.4% | -9.0% |
Return vs Industry: SN. underperformed the UK Medical Equipment industry which returned -19.4% over the past year.
Return vs Market: SN. underperformed the UK Market which returned -7.8% over the past year.
Price Volatility
SN. volatility | |
---|---|
SN. Average Weekly Movement | 4.6% |
Medical Equipment Industry Average Movement | 5.5% |
Market Average Movement | 5.4% |
10% most volatile stocks in GB Market | 10.8% |
10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: SN. is not significantly more volatile than the rest of UK stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: SN.'s weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1856 | 18,000 | Deepak Nath | https://www.smith-nephew.com |
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems.
Smith & Nephew plc Fundamentals Summary
SN. fundamental statistics | |
---|---|
Market Cap | US$11.10b |
Earnings (TTM) | US$496.00m |
Revenue (TTM) | US$5.21b |
22.4x
P/E Ratio2.1x
P/S RatioIs SN. overvalued?
See Fair Value and valuation analysisEarnings & Revenue
SN. income statement (TTM) | |
---|---|
Revenue | US$5.21b |
Cost of Revenue | US$1.48b |
Gross Profit | US$3.73b |
Other Expenses | US$3.24b |
Earnings | US$496.00m |
Last Reported Earnings
Jul 02, 2022
Next Earnings Date
n/a
Earnings per share (EPS) | 0.57 |
Gross Margin | 71.59% |
Net Profit Margin | 9.51% |
Debt/Equity Ratio | 50.3% |
How did SN. perform over the long term?
See historical performance and comparisonDividends
2.9%
Current Dividend Yield66%
Payout RatioDoes SN. pay a reliable dividends?
See SN. dividend history and benchmarksSmith & Nephew dividend dates | |
---|---|
Ex Dividend Date | Sep 29 2022 |
Dividend Pay Date | Oct 26 2022 |
Days until Ex dividend | 45 days |
Days until Dividend pay date | 72 days |
Does SN. pay a reliable dividends?
See SN. dividend history and benchmarks